Kilitch Drugs (India) Limited (BOM:524500)

Kilitch Drugs (India) Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	2,372	2,355	1,983	1,544	1,396	1,142
Revenue Growth	14.04%	18.74%	28.47%	10.58%	22.20%	66.71%
Gross Profit Gross Profit Growth	1,123	1,088	930.05	749.8	641.83	468.49
Operating Income Operating Income Growth	336.88	342.67	291.98	223.02	148.56	100.16
Net Income Net Income Growth	300.54	301.66	267.01	146.01	104.48	73.67
Earnings Per Share EPS Growth	8.69	8.91	16.60	4.58	3.35	2.36
EPS Growth	-1.60%	-46.33%	262.19%	36.71%	41.76%	99.58%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	1,025	862.49	706.43	567.76	413.34
Export Export Growth	1,328	1,110	829.63	820.82	716.25
Unallocated Unallocated Growth	1.26	10.79	7.66	7.41	12.76
Total Total Growth	2,355	1,983	1,544	1,396	1,142

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	687.39	687.39	593.66	690.71	591.77	572.96
Total Debt Total Debt Growth	887.09	887.09	494.24	316.47	221.94	204.32
Net Cash (Debt) Net Cash Growth	-199.7	-199.7	99.42	374.25	369.83	368.64
Net Cash Growth	-	-	-73.44%	1.19%	0.32%	8.11%
Net Cash Per Share Net Cash Per Share Growth	-5.78	-5.90	6.18	11.75	11.87	11.84

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	239.58	175.42	-15.35	25.86	57.83
Capital Expenditures CapEx Growth	-	-995.07	-468.73	-64.5	-38.12	-82.02
Free Cash Flow Free Cash Flow Growth	-	-755.5	-293.31	-79.85	-12.26	-24.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	47.33%	46.20%	46.90%	48.57%	45.98%	41.01%
Operating Margin	14.20%	14.55%	14.72%	14.45%	10.64%	8.77%
Pretax Margin	16.47%	16.42%	17.38%	12.54%	8.61%	8.42%
Profit Margin	12.67%	12.81%	13.46%	9.46%	7.48%	6.45%
FCF Margin	-	-32.08%	-14.79%	-5.17%	-0.88%	-2.12%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	22.38	14.78	21.77	42.94	20.81	35.47
PS Ratio	2.87	1.89	2.93	4.06	1.56	2.29

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error